Avricore Health Valuation
| AVCR Stock | CAD 0.04 0.01 12.50% |
Avricore Health seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of Avricore Health from analyzing the firm fundamentals such as Current Valuation of 4.31 M, profit margin of 0.02 %, and Return On Equity of 0.048 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Avricore Health's price fluctuation is out of control at this time. Calculation of the real value of Avricore Health is based on 3 months time horizon. Increasing Avricore Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Avricore stock is determined by what a typical buyer is willing to pay for full or partial control of Avricore Health. Since Avricore Health is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Avricore Stock. However, Avricore Health's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.045 | Real 0.042 | Hype 0.05 | Naive 0.0436 |
The intrinsic value of Avricore Health's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Avricore Health's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Avricore Health helps investors to forecast how Avricore stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Avricore Health more accurately as focusing exclusively on Avricore Health's fundamentals will not take into account other important factors: Avricore Health Total Value Analysis
Avricore Health is presently forecasted to have takeover price of 4.31 M with market capitalization of 4.56 M, debt of 40 K, and cash on hands of 122.09 K. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Avricore Health fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
4.31 M | 4.56 M | 40 K | 122.09 K |
Avricore Health Investor Information
The company has price-to-book (P/B) ratio of 1.83. Some equities with similar Price to Book (P/B) outperform the market in the long run. Avricore Health last dividend was issued on the 21st of November 2016. The entity had 1:4 split on the 21st of November 2016. Avricore Health is not in a good financial situation at the moment. It has a very high risk of going through financial straits in April.Avricore Health Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Avricore Health has an asset utilization ratio of 137.31 percent. This indicates that the Company is making C$1.37 for each dollar of assets. An increasing asset utilization means that Avricore Health is more efficient with each dollar of assets it utilizes for everyday operations.Avricore Health Ownership Allocation
Avricore Health holds a total of 101.29 Million outstanding shares. Avricore Health shows 10.19 percent of its outstanding shares held by insiders and 0.0 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Avricore Health Profitability Analysis
The company reported the revenue of 3.49 M. Net Loss for the year was (701.22 K) with profit before overhead, payroll, taxes, and interest of 1.79 M.About Avricore Health Valuation
Our relative valuation model uses a comparative analysis of Avricore Health. We calculate exposure to Avricore Health's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Avricore Health's related companies.Avricore Health Inc. manufactures and sells over-the-counter products in Canada. Avricore Health Inc. was founded in 1996 and is headquartered in Vancouver, Canada. AVRICORE HEALTH operates under Drug Manufacturers - Specialty Generic classification in Canada and is traded on TSX Venture Exchange.
Additional Tools for Avricore Stock Analysis
When running Avricore Health's price analysis, check to measure Avricore Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avricore Health is operating at the current time. Most of Avricore Health's value examination focuses on studying past and present price action to predict the probability of Avricore Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avricore Health's price. Additionally, you may evaluate how the addition of Avricore Health to your portfolios can decrease your overall portfolio volatility.